Ocumension Therapeutics (Shanghai) Co., Ltd
3 clinical trials · Sponsor
◉ Watch Ocumension Therapeutics (Shanghai) Co., Ltd
| Record | Firm | Date |
|---|---|---|
| Study of OT202 in Treating Moderate to Severe Dry Eye (NCT06435182) | Ocumension Therapeutics (Shanghai) Co., Ltd | 2023-04-10 |
| Study of Dexycu in Treating Intraocular Inflammation (NCT06429306) | Ocumension Therapeutics (Shanghai) Co., Ltd | 2022-08-22 |
| A Real-world Study of DEXYCU in the Treatment of Inflammation After Cataract Surgery (NCT06497699) | Ocumension Therapeutics (Shanghai) Co., Ltd | 2021-10-28 |
Track Ocumension Therapeutics (Shanghai) Co., Ltd automatically
Every clearance here is in the API, with alerts when new ones post.